ArticleBMC cancer2017
Anti-tumor effects of everolimus and metformin are complementary and glucose-dependent in breast cancer cells.
Gerke Ariaans et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
33 papers cite it
this papercites it